Sherertz RJ - Search Results

1

Recognition and prevention of nosocomial vascular device and related bloodstream infections in the intensive care unit.

Chittick P, Sherertz RJ. Chittick P, et al. Among authors: sherertz rj. Crit Care Med. 2010 Aug;38(8 Suppl):S363-72. doi: 10.1097/CCM.0b013e3181e6cdca. Crit Care Med. 2010. PMID: 20647794 Review.

2

Evaluation of the flush characteristics of 2 peripheral vascular catheters.

Chittick P, Sherertz RJ. Chittick P, et al. Among authors: sherertz rj. Infect Control Hosp Epidemiol. 2010 Dec;31(12):1311-3. doi: 10.1086/657586. Infect Control Hosp Epidemiol. 2010. PMID: 21047185 No abstract available.

3

Update on vascular catheter infections.

Sherertz RJ. Sherertz RJ. Curr Opin Infect Dis. 2004 Aug;17(4):303-7. doi: 10.1097/01.qco.0000136925.52673.16. Curr Opin Infect Dis. 2004. PMID: 15241073 Review.

4

Surveillance for infections associated with vascular catheters.

Sherertz RJ. Sherertz RJ. Infect Control Hosp Epidemiol. 1996 Nov;17(11):746-52. doi: 10.1086/647222. Infect Control Hosp Epidemiol. 1996. PMID: 8934244 Review.

5

Gamma radiation-sterilized, triple-lumen catheters coated with a low concentration of chlorhexidine were not efficacious at preventing catheter infections in intensive care unit patients.

Sherertz RJ, Heard SO, Raad II, Gentry L, Bowton D, Scuderi P, Hu J, Carruth W, Satishchandra B, Pepe J, Mosenthal A, Burke T, Dupuis J. Sherertz RJ, et al. Antimicrob Agents Chemother. 1996 Sep;40(9):1995-7. doi: 10.1128/AAC.40.9.1995. Antimicrob Agents Chemother. 1996. PMID: 8878569 Free PMC article. Clinical Trial.

6

Stability and compatibility of antimicrobial lock solutions.

Bookstaver PB, Rokas KE, Norris LB, Edwards JM, Sherertz RJ. Bookstaver PB, et al. Among authors: sherertz rj. Am J Health Syst Pharm. 2013 Dec 15;70(24):2185-98. doi: 10.2146/ajhp120119. Am J Health Syst Pharm. 2013. PMID: 24296841

7

A randomized, controlled trial of a new vascular catheter flush solution (minocycline-EDTA) in temporary hemodialysis access.

Bleyer AJ, Mason L, Russell G, Raad II, Sherertz RJ. Bleyer AJ, et al. Among authors: sherertz rj. Infect Control Hosp Epidemiol. 2005 Jun;26(6):520-4. doi: 10.1086/502578. Infect Control Hosp Epidemiol. 2005. PMID: 16018426 Clinical Trial.

8

Education of physicians-in-training can decrease the risk for vascular catheter infection.

Sherertz RJ, Ely EW, Westbrook DM, Gledhill KS, Streed SA, Kiger B, Flynn L, Hayes S, Strong S, Cruz J, Bowton DL, Hulgan T, Haponik EF. Sherertz RJ, et al. Ann Intern Med. 2000 Apr 18;132(8):641-8. doi: 10.7326/0003-4819-132-8-200004180-00007. Ann Intern Med. 2000. PMID: 10766683 Clinical Trial.

9

Outbreak of Candida bloodstream infections associated with retrograde medication administration in a neonatal intensive care unit.

Sherertz RJ, Gledhill KS, Hampton KD, Pfaller MA, Givner LB, Abramson JS, Dillard RG. Sherertz RJ, et al. J Pediatr. 1992 Mar;120(3):455-61. doi: 10.1016/s0022-3476(05)80920-5. J Pediatr. 1992. PMID: 1538298

10

The role of chelators in preventing biofilm formation and catheter-related bloodstream infections.

Raad II, Fang X, Keutgen XM, Jiang Y, Sherertz R, Hachem R. Raad II, et al. Curr Opin Infect Dis. 2008 Aug;21(4):385-92. doi: 10.1097/QCO.0b013e32830634d8. Curr Opin Infect Dis. 2008. PMID: 18594291 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

93 results

Search Page

Filters